The scientists behind Australia’s first locally developed mRNA COVID-19 vaccine candidate have published a preclinical study demonstrating the vaccine's potential to overcome the issue of ‘immune imprinting.’
Researchers say Australia’s first mRNA vaccine candidate could address COVID ‘immune imprinting’
December 18, 2024 Australian BiotechLatest Video
New Stories
-
Make the institution and its nobility work for patients, not the other way around
January 16, 2025 - - Latest News -
Could this system's 'nobility' embrace a new idea, even if they recognised it?
January 15, 2025 - - Latest News -
Patients do not live their condition as aggregated economic models
January 14, 2025 - - Latest News -
Delays were the intended outcome, not an unintended consequence
January 13, 2025 - - Latest News -
Attitudes may have evolved, but the framework they created remains virtually unchanged
January 13, 2025 - - Latest News -
Boehringer Ingelheim's Auckland office leads sustainability in NZ pharma sector
January 10, 2025 - - Latest News -
Companies welcome November PBAC outcomes
December 23, 2024 - - Latest News